Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Active Not Recruiting Phase 1 Trials for Ranitidine (DB00863)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0115568 (Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm) | Active Not Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04681105 | Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies | Treatment |